Novel imidazolidine compounds as androgen receptor modulators

Details for Australian Patent Application No. 2009290849 (hide)

Owner Galapagos NV

Inventors Nique, Francois; Jagerschmidt, Catherine; Blanque, Roland; Lefrancois, JeanMichel; Peixoto, Christophe; Deprez, Pierre; Triballeau, Nicolas; Wigerinck, Piet Tom Bert Paul; Namour, Florence Sylvie

Agent Davies Collison Cave

Pub. Number AU-A-2009290849

PCT Pub. Number WO2010/029119

Priority 0900333.6 09.01.09 GB; 61/191,918 11.09.08 US

Filing date 10 September 2009

Wipo publication date 18 March 2010

International Classifications

C07D 233/60 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4166 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 233/66 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/029119 Priority application(s): WO2010/029119

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009290861-Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs

2009290848-Method for identifying compounds useful for increasing the functional activity and cell surface expression of CFassociated mutant Cystic Fibrosis transmembrane conductance regulator